The measures, with eight chapters and 58 articles in total, set new requirements for sampling, inspection, reinspection, supervision and administration of drugs, further standardizes the work of drug quality sampling and inspection, and clarifies the responsibilities of drug regulatory departments at all levels.

The introduction of the new measures is not only a signal to further fight the drug safety regulatory war, but also indicates that the relevant detection and analysis instruments will usher in another development opportunity.On the one hand, under the stricter management mode of spot check, pharmaceutical enterprises are bound to pay more attention to drug quality self-check and strengthen quality control.On the other hand, in order to improve the efficiency and accuracy of testing, major testing institutions will further optimize the configuration and increase the introduction of instruments.

Strictly control the quality of drugs, equipment-LWGS sanitary turbine flowmeter and heavy responsibilities.As the basis of drug quality control, the quality and performance of the detection and analysis instrument will have an impact on the whole drug quality sampling management, and even determine whether the final drug quality is up to standard.Based on this, the instrument industry should constantly improve the performance of their products to ensure the efficiency and accuracy of the instrument.In addition, the instrument industry should also see the current analysis of the shortcomings of testing instruments in China, accelerate the development and production of high-end products, to achieve the self-sufficiency of sophisticated instruments.